Insights on withdrawal risks, gradual tapering strategies, and patient-centered support It’s about supporting the ...

Parkinson’s disease is a long-term condition that slowly gets worse over time. It affects the brain and nervous system, making it harder for people to move normally. Common symptoms include shaking, ...

An investigational oral medication conferred an increase in annualized height velocity at 1 year among children and ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Because keeping yourself steady is more important than you think.

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

If you’ve ever rolled over in bed and suddenly felt the room spin for a few seconds, you are not alone. Many people assume this sensation is from just getting older, low blood sugar or something that ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found. This rate of weight regain is significantly faster than ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. On December 23, the Centers for Medicare and Medicaid ...

While the media mogul has been candid about her use of GLP-1s for weight loss, she recently revealed an unexpected result of the medication: She no longer drinks alcohol. “I was a big fan of tequila,” ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi and AstraZeneca) ...